NovaBridge Biosciences financial data

Symbol
NBP on Nasdaq
Location
Rockville, MD
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 03 Apr 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 187,452,495 shares 0.99%
Common Stock, Shares, Outstanding 188,108,178 shares
Common Stock, Value, Issued $19,000 USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $165,404,000 USD
Assets, Current $167,640,000 USD
Property, Plant and Equipment, Net $172,000 USD
Operating Lease, Right-of-Use Asset $3,209,000 USD
Other Assets, Noncurrent $1,219,000 USD
Assets $206,708,000 USD
Employee-related Liabilities, Current $1,313,000 USD
Liabilities, Current $7,347,000 USD
Operating Lease, Liability, Noncurrent $2,628,000 USD
Other Liabilities, Noncurrent $0 USD -100%
Liabilities $9,975,000 USD
Accumulated Other Comprehensive Income (Loss), Net of Tax $37,039,000 USD
Retained Earnings (Accumulated Deficit) $1,294,693,000 USD
Stockholders' Equity Attributable to Parent $196,733,000 USD -18%
Liabilities and Equity $206,708,000 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 800,000,000 shares
Common Stock, Shares, Issued 188,108,178 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $165,404,000 USD 8.8%
Deferred Tax Assets, Valuation Allowance $56,015,000 USD 42%
Operating Lease, Liability $3,481,000 USD
Lessee, Operating Lease, Liability, to be Paid $3,929,000 USD
Property, Plant and Equipment, Gross $425,000 USD -84%
Operating Lease, Liability, Current $853,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,069,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $1,040,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $448,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $557,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $34,484,000 USD 37%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $337,000 USD
Deferred Tax Assets, Net of Valuation Allowance $844,000 USD